Hikma Pharmaceuticals shrinks stake

24th May 2013 15:36

Said Darwazah, the Chief Executive Officer of Hikma Pharmaceuticals, has reduced his stake in the FTSE 250 company, it was announced after Thursday's close.The director, who was the Minister of Health for the Hashemite Kingdom of Jordan from 2003 to 2006, sold 188,445 shares over a period of six days after the company reported a strong start to the year. Sold at 988p each, the trade value of the shares totalled £1.86m. The multinational pharmaceutical group earlier this month said that following a good performance in both the Branded and Injectables businesses, the company is on track to meet its current full-year guidance. It also reported that the Generics business has delivered revenue ahead of its original expectations, and as such, group sales are set to grow around 13% in 2013, having previously been forecast to rise 10%. Darwazah, whose direct stake in the company now stands at 5.58%, said it had been a "very good start to 2013". Top Director BuysPureCircle Ltd. (DI) (PURE) Director name: Mr William MitchellAmount purchased: 30,000 @ 335.00p Value: £100,500New Britain Palm Oil Ltd. (DI) (NBPO) Director name: Mr Alan ChaytorAmount purchased: 10,000 @ 375.00p Value: £37,500Halfords Group (HFD) Director name: Mr Matt Davies Amount purchased: 10,000 @ 319.60p Value: £31,960Halfords Group (HFD) Director name: Mr Dennis H MillardAmount purchased: 10,000 @ 319.60p Value: £31,960F&C Asset Management (FCAM) Director name: Mr Edward BramsonAmount purchased: 32,000 @ 95.21p Value: £30,467F&C Asset Management (FCAM) Director name: Mr Edward BramsonAmount purchased: 32,000 @ 95.21p Value: £30,467Intu Properties (INTU) Director name: Ms Adèle AndersonAmount purchased: 7,500 @ 346.70p Value: £26,002NR